126 related articles for article (PubMed ID: 37037410)
1. Circumventing drug resistance through a CK2-targeted combination via attenuating endogenous AhR-TLS-promoted genomic instability in human colorectal cancer cells.
Chen F; Wang Z; Wang Y; Gou S
Food Chem Toxicol; 2023 Jun; 176():113774. PubMed ID: 37037410
[TBL] [Abstract][Full Text] [Related]
2. Blockade of chemo-resistance to 5-FU by a CK2-targeted combination via attenuating AhR-TLS-promoted genomic instability in human colon cancer cells.
Wang Z; Chen F; Wang Y; Gou S
Toxicol Appl Pharmacol; 2023 Sep; 475():116647. PubMed ID: 37543059
[TBL] [Abstract][Full Text] [Related]
3. Breakdown of chemo-immune resistance by a TDO2-targeted Pt(IV) prodrug via attenuating endogenous Kyn-AhR-AQP4 metabolic circuity and TLS-promoted genomic instability.
Chen F; Xu G; Tian W; Gou S
Biochem Pharmacol; 2021 Nov; 193():114785. PubMed ID: 34562469
[TBL] [Abstract][Full Text] [Related]
4. APIM-Mediated REV3L⁻PCNA Interaction Important for Error Free TLS Over UV-Induced DNA Lesions in Human Cells.
Ræder SB; Nepal A; Bjørås KØ; Seelinger M; Kolve RS; Nedal A; Müller R; Otterlei M
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597836
[TBL] [Abstract][Full Text] [Related]
5. ATR mediates cisplatin resistance in 3D-cultured breast cancer cells via translesion DNA synthesis modulation.
Gomes LR; Rocha CRR; Martins DJ; Fiore APZP; Kinker GS; Bruni-Cardoso A; Menck CFM
Cell Death Dis; 2019 Jun; 10(6):459. PubMed ID: 31189884
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
Sanders MA; Haynes B; Nangia-Makker P; Polin LA; Shekhar MP
J Biol Chem; 2017 Jun; 292(25):10347-10363. PubMed ID: 28490629
[TBL] [Abstract][Full Text] [Related]
7. Role of polyamines in determining the cellular response to chemotherapeutic agents: modulation of protein kinase CK2 expression and activity.
Kreutzer JN; Olsen BB; Lech K; Issinger OG; Guerra B
Mol Cell Biochem; 2011 Oct; 356(1-2):149-58. PubMed ID: 21750985
[TBL] [Abstract][Full Text] [Related]
8. REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells.
Wang W; Sheng W; Yu C; Cao J; Zhou J; Wu J; Zhang H; Zhang S
Oncol Rep; 2015 Sep; 34(3):1460-8. PubMed ID: 26165320
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related (
Combès E; Andrade AF; Tosi D; Michaud HA; Coquel F; Garambois V; Desigaud D; Jarlier M; Coquelle A; Pasero P; Bonnefoy N; Moreaux J; Martineau P; Del Rio M; Beijersbergen RL; Vezzio-Vie N; Gongora C
Cancer Res; 2019 Jun; 79(11):2933-2946. PubMed ID: 30987998
[TBL] [Abstract][Full Text] [Related]
10. Kynurenine Signaling Increases DNA Polymerase Kappa Expression and Promotes Genomic Instability in Glioblastoma Cells.
Bostian AC; Maddukuri L; Reed MR; Savenka T; Hartman JH; Davis L; Pouncey DL; Miller GP; Eoff RL
Chem Res Toxicol; 2016 Jan; 29(1):101-8. PubMed ID: 26651356
[TBL] [Abstract][Full Text] [Related]
11. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
12. DNA polymerase eta: A potential pharmacological target for cancer therapy.
Saha P; Mandal T; Talukdar AD; Kumar D; Kumar S; Tripathi PP; Wang QE; Srivastava AK
J Cell Physiol; 2021 Jun; 236(6):4106-4120. PubMed ID: 33184862
[TBL] [Abstract][Full Text] [Related]
13. Different sets of translesion synthesis DNA polymerases protect from genome instability induced by distinct food-derived genotoxins.
Temviriyanukul P; Meijers M; van Hees-Stuivenberg S; Boei JJ; Delbos F; Ohmori H; de Wind N; Jansen JG
Toxicol Sci; 2012 May; 127(1):130-8. PubMed ID: 22331492
[TBL] [Abstract][Full Text] [Related]
14. JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells.
Xu W; Chen Q; Wang Q; Sun Y; Wang S; Li A; Xu S; Røe OD; Wang M; Zhang R; Yang L; Zhou J
Cell Death Dis; 2014 Dec; 5(12):e1551. PubMed ID: 25476899
[TBL] [Abstract][Full Text] [Related]
15. REV3L, the catalytic subunit of DNA polymerase ζ, is involved in the progression and chemoresistance of esophageal squamous cell carcinoma.
Zhu X; Zou S; Zhou J; Zhu H; Zhang S; Shang Z; Ding WQ; Wu J; Chen Y
Oncol Rep; 2016 Mar; 35(3):1664-70. PubMed ID: 26752104
[TBL] [Abstract][Full Text] [Related]
16. Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress tolerance.
Tarantino D; Walker C; Weekes D; Pemberton H; Davidson K; Torga G; Frankum J; Mendes-Pereira AM; Prince C; Ferro R; Brough R; Pettitt SJ; Lord CJ; Grigoriadis A; Nj Tutt A
Oncogene; 2022 Aug; 41(32):3969-3977. PubMed ID: 35768547
[TBL] [Abstract][Full Text] [Related]
17. Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines.
Noordhuis P; Laan AC; van de Born K; Honeywell RJ; Peters GJ
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344863
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance-mediated oxaliplatin chemoresistance in colorectal cancer.
Xu Y; Hao J; Chen Q; Qin Y; Qin H; Ren S; Sun C; Zhu Y; Shao B; Zhang J; Wang H
Mol Carcinog; 2024 Feb; 63(2):224-237. PubMed ID: 37861356
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.
Salizzato V; Borgo C; Cesaro L; Pinna LA; Donella-Deana A
Oncotarget; 2016 Apr; 7(14):18204-18. PubMed ID: 26919095
[TBL] [Abstract][Full Text] [Related]
20. Role of protein kinase CK2 in antitumor drug resistance.
Borgo C; Ruzzene M
J Exp Clin Cancer Res; 2019 Jul; 38(1):287. PubMed ID: 31277672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
